Monografie
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
- Sprache
-
Englisch
- Identifier
-
1234388413
- Beteiligte Personen und Organisationen
-
Vaca, Hugo Rolando
Celentano, Ana María
Toscanini, María Agustina
Heimburg, Tino
Ghazy, Ehab
Zeyen, Patrik
Hauser, Alexander-Thomas
Oliveira, Guilherme
Elissondo, María Celina
Jung, Manfred
Sippl, Wolfgang
Camicia, Federico
Rosenzvit, Mara Cecilia
- DOI
-
10.1371/journal.pntd.0009226
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Vaca, Hugo Rolando
- Celentano, Ana María
- Toscanini, María Agustina
- Heimburg, Tino
- Ghazy, Ehab
- Zeyen, Patrik
- Hauser, Alexander-Thomas
- Oliveira, Guilherme
- Elissondo, María Celina
- Jung, Manfred
- Sippl, Wolfgang
- Camicia, Federico
- Rosenzvit, Mara Cecilia
Ähnliche Objekte (12)
Development of class IIa histone deacetylase inhibitors
Histone deacetylase inhibitor valproic acid in pancreas differentiation
New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Sensitization by histone deacetylase inhibitors of receptor mediated hepatic apoptosis
Modulation of posttranscriptional and posttranslational regulatory processes by histone deacetylase inhibitors
Chemoproteomics-based target deconvolution and selectivity profiling of Histone Deacetylase inhibitors
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Histone deacetylase 6 inhibitor JS28 prevents pathological gene expression in cardiac myocytes
Design and Synthesis of Histone Deacetylase Inhibitors with Antiplasmodial and Anticancer Activities
Development of class IIa histone deacetylase inhibitors
Histone deacetylase inhibitor valproic acid in pancreas differentiation
New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Sensitization by histone deacetylase inhibitors of receptor mediated hepatic apoptosis
Modulation of posttranscriptional and posttranslational regulatory processes by histone deacetylase inhibitors
Chemoproteomics-based target deconvolution and selectivity profiling of Histone Deacetylase inhibitors
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Histone deacetylase 6 inhibitor JS28 prevents pathological gene expression in cardiac myocytes
Design and Synthesis of Histone Deacetylase Inhibitors with Antiplasmodial and Anticancer Activities
Development of class IIa histone deacetylase inhibitors
Histone deacetylase inhibitor valproic acid in pancreas differentiation
New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Sensitization by histone deacetylase inhibitors of receptor mediated hepatic apoptosis
Modulation of posttranscriptional and posttranslational regulatory processes by histone deacetylase inhibitors
Chemoproteomics-based target deconvolution and selectivity profiling of Histone Deacetylase inhibitors
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Histone deacetylase 6 inhibitor JS28 prevents pathological gene expression in cardiac myocytes